• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Transplant. Fatal outcome in a liver transplant recipient with COVID-19

tetano

Editor, Senior Moderator
Am J Transplant. 2020 Apr 10. doi: 10.1111/ajt.15909. [Epub ahead of print]
Fatal outcome in a liver transplant recipient with COVID-19.


Huang JF[SUP]1[/SUP], Zheng KI[SUP]2[/SUP], George J[SUP]3[/SUP], Gao HN[SUP]4[/SUP], Wei RN[SUP]5[/SUP], Yan HD[SUP]6[/SUP], Zheng MH[SUP]2,[/SUP][SUP]7,[/SUP][SUP]8[/SUP].

Author information




Abstract

Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplantation. We describe a case of COVID-19 in a patient who had transplantation three years previously for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multi-organ failure. Despite multiple invasive procedures and rescue therapies, he succumbed to the disease. The management of COVID-19 in the post-transplant setting presents complex challenges emphasizing the importance of strict prevention strategies.
This article is protected by copyright. All rights reserved.



KEYWORDS:

COVID-19; liver; transplantation


PMID:32277591DOI:10.1111/ajt.15909
 
Back
Top